James E. Levine Cardiff Oncology, Inc. (CRDF) insider trading activity

CRDF Quotes by TradingView

James E. Levine is Chief Financial Officer of Cardiff Oncology, Inc.. Currently has a direct ownership of 60,000 shares of CRDF, which is worth approximately $162,600. The most recent transaction as insider was on Sep 16, 2022, when has been sold 30,000 shares (Common Stock) at a price of $1.56 per share, resulting in proceeds of $46,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60K
0% 3M change
0% 12M change
Total Value Held $162,600

James E. Levine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2022
BUY
Open market or private purchase
$46,800 $1.56 p/Share
30,000 Added 33.33%
60,000 Common Stock
Sep 10 2021
BUY
Open market or private purchase
$194,400 $6.48 p/Share
30,000 Added 50.0%
30,000 Common Stock

Also insider at

CDTX
Cidara Therapeutics, Inc. Healthcare
Chief Financial Officer
JEL

James E. Levine

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on CRDF

Follow Cardiff Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRDF shares.

Notify only if

Insider Trading

Get notified when an Cardiff Oncology, Inc. insider buys or sells CRDF shares.

Notify only if

News

Receive news related to Cardiff Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRDF